Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-15T00:19:56.449Z Has data issue: false hasContentIssue false

Chapter 7 - Drug Misuse in Older People

Old Problems and New Challenges

from Section 1 - Epidemiology and Types of Disorders

Published online by Cambridge University Press:  12 September 2020

By
Ajay Wagle  and
Vellingiri Raja Badrakalimuthu
Edited by
Julian C. Hughes  and
Philippa Lilford
Julian C. Hughes
Affiliation:
University of Bristol
Philippa Lilford
Affiliation:
Severn Deanery, University of Bristol
Get access

Summary

An increase in the population of older people, associated with the increasing demand for holistic care to meet their complex needs, has focused attention on substance misuse in older adults. There is growing awareness among health and social care professionals of the challenges that older adults face in accessing and receiving appropriate treatment for substance misuse and the need for policy revisions to define an inclusive substance misuse service that will be able to address addiction and the impact on physical, mental and social well-being of vulnerable and frail older people.

Type
Chapter
Information
Clinical Topics in Old Age Psychiatry , pp. 105 - 115
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Atkinson, MR. Substance abuse in elderly, In Psychiatry in the Elderly (eds Jacoby, R, Oppenheimer, C) 799–834 Oxford University Press, 2002.Google Scholar
Coulthard, M, Farrell, M, Singleton, N et al. Tobacco, Alcohol and Drug Use and Mental Health. TSO (The Stationery Office) 2002.Google Scholar
McInnes, E, Powell, J. Drug and alcohol referrals. Are elderly substance abuse diagnosis and referrals missed? BMJ 1994; 308; 444–446.CrossRefGoogle ScholarPubMed
Fahmy, V, Hatch, SL, Hotopf M and Stewart R. Prevalence of illicit drug use in people aged 50 years and over from two surveys. Age Ageing (2012); 41, 553–556.Google Scholar
White, JB, Duncan, DF, Bradley, D et al. Generational shift and drug abuse in older Americans. J Soc Behav Health Sci (2011); 5; 58–66.Google Scholar
Moore, AA, Karno, MP, Grella, CE et al. Alcohol, tobacco, and non-medical drug use in older US adults: data from the 2001/02 National Epidemiological Survey of Alcohol and Related Conditions. J Am Geriatr Soc (2009); 57; 2275–2281.Google Scholar
Lin, JC, Karno, MP, Grella, CE et al. Alcohol, tobacco, and non-medical drug use in US adults aged 65 and older: Data from the 2001/02 National Epidemiological Survey of Alcohol and Related Conditions. Am J Geriatr Psychiatry (2011); 19; 291–299.Google Scholar
Blazer, DG and Wu, LT. The epidemiology of substance use and disorders among middle aged and elderly community adults: National Survey on Drug Use and Health (NSDUH). Am J Geriatr Psychiatry (2009); 17;237–245.Google Scholar
Johnson, SD, Striley C and Cottlet LB. Comorbid substance use and HIV risk in older African American drug users. J Aging Health (2007); 19; 646–658.Google Scholar
Lofwall, MR, Schuster A and Strain SK. Changing profile of abused substances by older persons entering treatment. J Nerv Ment Dis (2008); 196; 898–905.Google Scholar
Morgan, K, Dallosso, H, Ebrahim, S et al. Prevalence, frequency, and duration of hypnotic drug use among elderly living at home. BMJ (Clinical Research Edn 1988); 296; 601–602.CrossRefGoogle ScholarPubMed
Centre for Behavioral Health Statistics and Quality Results from the 2011 National Survey on Drug Use and Health: Mental Health Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville MD (2012).Google Scholar
Cimolai, N. Zopiclone: is it a pharmacological agent for abuse? Canadian Family Physician (2007); 53; 2124–2129.Google Scholar
Higgitt, AC. Indications for benzodiazepine prescriptions in the elderly. Int J Geriatr Psychiatry (1988); 3; 239–243.Google Scholar
Lechevallier, N, Fourier, A, Berr, C. Benzodiazepines in the elderly. The EVA study [In French] Revuew d’Epidemiologieet de Sante Publique (2003); 51; 317–326.Google Scholar
Fernandez, L, Cassagne-Pinel, C. Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects. L’Encephale (2001); 27; 459–474.Google Scholar
Woo, BKP, Chen, W. Substance misuse among older patients in psychiatric emergency service. Gen Hosp Psychiatry (2010); 32; 99–101.CrossRefGoogle ScholarPubMed
Rajaratnam, R, Sivesind, D, Todman, M et al. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J Opioid Mang (2009); 5; 27–37.CrossRefGoogle ScholarPubMed
Beynon, CM, McVeigh, J and Roe, B. Problematic drug use, ageing and older people: trends in the age of drug users in northwest England, Ageing Soc (2007); 27; 799–810.CrossRefGoogle Scholar
Rivers, E, Shirazi, E, Aurora, T et al. Cocaine use in elderly patients presenting to an inner-city emergency department. Acad Emergency Med(2004); 11; 874–877.Google Scholar
Trafton, JA, Olivia, E, Horst, D et al. Treatment needs associated with pain in substance use disorder patients. Implications of concurrent treatment. Drug and Alcohol Dependence (2004); 73; 23–31.CrossRefGoogle ScholarPubMed
Simoni-Wastila, L, Stricker, G. Risk Factors associated with problem use of prescription drugs. Am J Pub Health (2004); 94; 266–268.Google Scholar
Gottlieb, S. Inappropriate drug prescribing in elderly people is common. BMJ (2004); 329; 367.Google Scholar
Mossley, JM Shapiro, E. Physician use by elderly over an eight year period. J Pub Health (1985); 75; 133–134.Google Scholar
Gfroerer, J, Penne, M, Pemberton, M et al. Substance abuse treatment among older adults in 2020. The impact of aging baby-boom cohort. Drug and Alcohol Dependence (2003); 69; 127–135.Google Scholar
Hinkin, CH, Castellon, SA, Dickson-Fuhrman, E et al. Screening for drug and alcohol abuse among older adults using modified version of CAGE. Am J Addict (2001); 10; 319–326.Google Scholar
SAMHSA Treatment Episodes Data Set-Admissions (TEDS-A)-Concatenated, 1992–2010. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). ICPSR25221-v5. Inter-university Consortium for Political and Social Research, Ann Arbor, MI (2012).Google Scholar
Frischer, M, Crome, I, Macleod, J et al. Substance misuse and psychiatric illness: prospective observational study using the general practice database. J Epi Comm (2005); 59; 847–850.Google Scholar
Blixen, CE, McDougall, GJ, Suen, LJ. Dual diagnosis in elders discharged from a psychiatric hospital. Int J Geriatr Psychiatry (1997); 12; 307–313.Google Scholar
Rosen, D, Smith, ML, Reynolds, CF. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry (2008); 16; 488–497.Google Scholar
Torres, LR, Kaplan, C, Valdez, A. Health consequences of long-term injection heroin use among aging Mexican American men. J Aging Health (2011); 23; 912–932.CrossRefGoogle ScholarPubMed
McMorn, S, Schoedel, KA, Sellers, EM. Effects of low-dose opioids on cognitive dysfunction. JCO (2011); 29; 4342–4343.Google Scholar
Sartre, DD, Blow, FC, Chi, Fw, Weisner, C. Gender differences in seven-year alcohol and drug treatment outcomes among older adults. Am J Addict (2007); 16; 216–221.CrossRefGoogle Scholar
Outlaw, FH, Marquart, JM, Roy, A et al. Treatment outcomes for older adults who abuse substances. J Appl Gereontol (2012); 31; 78–100.CrossRefGoogle Scholar
Miller, PM, Brooks, SW & Stewart, SH. Medical treatment of alcohol dependence: a systematic review. Int J of Psychiatry Med (2011); 42; 227–66.Google Scholar
Picton, JD, Marino, AD & Nealy, KL. Benzodiazepine use and cognitive decline in the elderly. Am J of Health-Sys Pharm (2018); 75; e6–e12CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×